Section Arrow
Quote
ARCT.NASDAQ
- Arcturus Therapeutics Holdings
Quotes are at least 15-min delayed:2025/07/18 18:15 EDT
After Hours
Last
 13.64
+0.14 (+1.04%)
Bid
13.31
Ask
13.8
High 13.8 
Low 13.31 
Volume 15311 
Regular Hours
Last
 13.5
-0.04 (-0.30%)
Day High 
14.02 
Prev. Close
13.54 
1-M High
15.2 
Volume 
278.19K 
Bid
13.31
Ask
13.8
Day Low
13.49 
Open
13.73 
1-M Low
12.03 
Market Cap 
367.21M 
Currency USD 
P/E 7.2 
%Yield 3.16 
10-SMA 13.68 
20-SMA 13.44 
50-SMA 12.65 
52-W High 25.88 
52-W Low 8.04 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.52/-3.90
Enterprise Value
392.21M
Balance Sheet
Book Value Per Share
8.62
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
205.76M
Operating Revenue Per Share
9.69
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
After Hours 2.14 -0.14 -6.14%
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
After Hours 13.9502 -0.1248 -0.89%
NCNANuCana plc0.0477+0.0009+1.92%-- 
After Hours 0.0469 -0.0008 -1.68%
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
After Hours 5.86 +0.02 +0.34%
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
After Hours 5.78 -0.14 -2.36%
Quotes are at least 15-min delayed：2025/07/18 18:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.